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 Reactive oxygen species (ROS) are recently recognized
to be beneficial to cells in regulating signal transduction in
plants and animals, a process called redox signaling [1-6]. This
process is initiated by a burst of intracellular ROS generation
stimulated by various growth factors and cytokines. ROS in
turn participate and regulate diverse downstream signaling
pathways leading to specific cellular functions [7-13]. One of
the targets for ROS in vivo is the reversible oxidation of phos-
phatases, which together with protein tyrosine kinases are re-
sponsible for maintaining a normal protein tyrosine phospho-
rylation-dephosphorylation homeostasis in cell signaling in
vivo [5,14].
Studies have revealed that the likely source for ROS gen-
eration is the membrane-bound superoxide-generating enzyme
NADPH oxidase [15]. The activity of NADPH oxidase is con-
trolled by a group of enzymatic components, including the
small GTP-binding proteins Rac and Ras. Rac may be involved
in regulating the levels of ROS after ligand-evoked activation
[16-19] or it may serve as an activator for cytosolic phospho-
lipase A2, which releases arachidonic acid from the membrane
for cellular functions [20]. Ras is known to act as a switch to
regulate signal transduction pathways that control cell prolif-
eration, differentiation, organization of actin cytoskeleton,
intracellular transport and survival [21-28]. Ras can be re-
cruited and anchored onto the inner surface of cell membrane
where it is modified and activated to Ras-GTP [29,30], as a
cellular redox regulator [16,31].
Among the various growth factors, PDGF is well-studied
in many cell types and used by many as a model system. PDGF
family consists of four gene products that form five dimeric
isoforms: αα, ββ, αβ, CC and DD [32]. Each isoform acts via
two receptor tyrosine kinases of PDGFRα and PDGFRβ in-
ducing dimerization of receptors and autophosphorylation of
distinctive tyrosines in the intracellular domain of the recep-
tor. The specifically phosphorylated tyrosine allows docking
and subsequent activation of a series of responding molecules
containing Src homology 2 or SH2 domains [33]. These in-
clude Src family kinases, phosphatidylinositol-3-kinase
(PI3K), phospholipase Cγ (PLCγ) and small GTP-binding pro-
tein Ras [34-36]. The specific binding of these molecules can
initiate signaling pathways leading to cell proliferation and
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pertussis toxin for cytokine-binding G protein coupled receptor (GPCR); PP1 for Src-family kinases; LY294002 for
phosphatidylinositol-3 kinase (PI3K). Small GTP-binding proteins Rac and Ras were studied using transfectants of domi-
nant negative Rac (Rac N17), Ras (Ras N17) or constitutively active Rac (Rac V12). Cell proliferation was quantified
using BrdU incorporation method.
Results: Inhibitions of PDGF receptor kinase, the docking protein component Src-family kinases, and the survival ele-
ment PI3K all eradicated PDGF-stimulated ROS production and corroborated with the suppressed cell growth. These
inhibitions also attenuated the activated ERK1/2, JNK, and Akt, all downstream targets of the above factors. Interestingly,
inhibiting GPCR or EGFR also showed the same effect but to a lesser degree. Co-inhibiting receptors to PDGF and EGF
with or without co-inhibiting GPCR eradicated the PDGF signaling system completely. Transiently transfected cells with
plasmid from small GTP-binding proteins Rac N17 or Ras N17 diminished PDGF action in ROS generation, cell prolif-
eration and MAP kinase activation, while cells with Rac V12 enhanced the PDGF effect.
Conclusions: Our data clarified the potential mechanism of PDGF signaling in the lens epithelial cells, in which con-
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motility [37,38]. In response to PDGF stimulation, there is a
crosstalk between signaling pathways leading to cell growth.
For example, Ras and PI3K have been demonstrated to inter-
act with, and mediate, each other [39,40]. Small GTP-binding
proteins Rac, Ras, and Rho have also been proven to activate
each other in several cell types [41-43].
In addition to growth factor receptors, the cells have G
protein coupled receptors (GPCRs) which consist of a group
of integral membrane proteins. These receptors respond to di-
verse external stimuli and subsequently interact with their re-
spective large G proteins to initiate various downstream path-
ways upon ligand binding [44]. GPCR is proposed to interact
with protein tyrosine kinase receptor (PTKR) binding during
growth factor stimulation, and subsequently activating Src-
family kinases and other upstream signaling components. It
has been reported that GPCR can combine with PDGFR to
form a functional signaling complex in human embryo kid-
ney cells [45]. However, whether GPCR interacts with PDGF
receptor in the lens is not clear.
Many of the PDGF isoforms are potent mitogens for lens
growth and development [46], including the recently discov-
ered effective PDGF-D [47]. We have used the PDGFββ
isoform in the past and found that human lens epithelial (HLE)
cells responded to its mitogenic action, and that action was
ROS-dependent. PDGF-stimulated ROS generation and the
downstream signal transduction in HLE cells could be abol-
ished when cells were preloaded with antioxidants or free ra-
dial scavengers. In addition, a range of low level exogenous
hydrogen peroxide could mimic the mitogenic effect of PDGF
[48]. The membrane NADPH oxidase is known to be the ma-
jor source of ROS in other cell types, and this enzyme has
been found in both the lens and lens epithelial cells [49,50].
Our preliminary studies have also shown that NADPH oxi-
dase was the main source of such ROS generation [51]. The
mechanism of PDGF signaling is largely unknown. To con-
tinue our quest for the understanding of PDGFββ signaling in
the lens, we focus on identifying the target proteins after PDGF
receptor (PDGFR) binding and prior to ROS generation by
using the PDGFR-rich HLE B3 cells as a model. The upstream
factors included PDGFR, Src-family kinases, PI3K and small
GTPase Ras and Rac. We also examined the possible crosstalk
between GPCR and PDGFR, and between EGFR and PDGFR
in the lens epithelial cells. Using both specific inhibitors, we
found that inhibiting either PDGFR, Src-family kinases or
PI3K prevented ROS production, MAPK activation or cell
proliferation in PDGF-stimulated cells. Dominant negative Ras
or Rac transfected HLE B3 cells switched off ROS generation
and the downstream signals while constitutively active Rac
would enhance them. Our data also suggest the presence of
crosstalk between PDGF receptor and the G-protein coupled
receptor, and also between PDGF receptor and EGF receptor
in the lens epithelial cells.
METHODS
 Lipofectamine™ Transfection, Plus Reagent, pcDNA 3.1+
and 2',7'-dichlorodihydrofluorescin diacetate (DCFDA) were
purchased from Invitrogen Corporation (Carlsbad, CA). Rac1
N17, Rac1 V12, and H-Ras N17 (HA-tagged) were purchased
from Guthrie cDNA Resource Center (Sayre, PA). Platelet-
derived growth factor (PDGF) ββ homodimer (human recom-
binant), Pertussis toxin (Bordetella pertussis) and AG1296,
4-[(3-bromophenyl) amino]-6,7-dimethoxyquinazoline
(AG1517) were obtained from Calbiochem (San Diego, CA).
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
(LY294002) and 4-amino-5-(4-methylphenyl)-7-(t-butyl)
pyrazolo [3,4-d] pyrimidine (PP1) were purchased from
BIOMOL International, LP (Plymouth Meeting, PA). Cell Pro-
liferation ELISA 5-bromodeoxyuridine or BrdU (chemilumi-
nescent) Kit, and Cytotoxicity Detection Kit (lactic acid de-
hydrogenase or LDH kit) were purchased from Roche Ap-
plied Sciences (Indianapolis, IN). Phospho-ERK1/2 mono-
clonal antibody, phospho-p38, phospho-SAPK/JNK, and
phospho-Akt polyclonal antibodies were all obtained from Cell
Signaling Technology Inc. (Beverly, MA). HA antibody and
horseradish peroxidase-conjugated secondary antibodies were
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA). Anti-G3PD (Glyceraldehyde-3 phosphate dehydroge-
nase) antibody was purchased from Research Diagnostics Inc.
(Flanders, NJ). SuperSignal West Pico Substrate was purchased
from Pierce Biotechnology Inc. (Rockford, IL). All other
chemicals and reagents were of analytical grade.
Cell Culture:  Human lens epithelial cell line, HLE B3,
was kindly provided by Usha Andley of Washington Univer-
sity (St. Louis, MO). Cells were grown and maintained in
medium consisting of MEM supplemented with 20% FBS and
50 µg/ml of gentamicin in a humidified 5% CO2 incubator.
Medium was changed every four days. For PDGF stimula-
tion, cells were gradually deprived of serum by first incubat-
ing in medium with 2% FBS overnight, then replacing into
serum-free medium for 30 min prior to each experiment.
Cell Transfection:  Lens epithelial cells are known to con-
tain several small GTP-binding proteins (23-27 kDa) includ-
ing Rac-1 and H-Ras [52]. In this report, we used Rac-1 and
H-Ras throughout the experiments. Rac N17, Rac V12 or Ras
N17 constructed with HA-tag (Hemagglutinin epitode) was
transfected into HLE B3 cells by using Lipofectamine™ Trans-
fection with Plus Reagents. Cells were seeded and cultured
overnight in 20% FBS-containing MEM. Lipofectamine trans-
fection with Plus Reagent, and plasmid DNA were added onto
cells in serum-free medium for 3 h. The cells were cultured in
20% FBS-containing medium for 48 h and then geneticin (800
µg/ml) was used to select the transfected cells. After selec-
tion, transiently transfected cells were maintained in medium
containing 400 µg/ml geneticin.
Quantitative image analysis of intracellular ROS in live
cells by confocal microscopy:  Human lens epithelial cells
(wild-type or transfected) were gradually deprived of serum
as described above. Cells were then loaded with 50 µM of
DCFDA for 5 min in the dark in a CO2 incubator before stimu-
lating by PDGF, following the method described in Chen et
al. [48]. In brief, after loading DCFDA, the dye was removed
and cells were washed twice with MEM-HEPES before im-
age collection. Un-stimulated cells exposed to UV light (from
confocal microscope) were used as the positive control for
375ROS reaction and dye-loading quality, while cells without
growth factor were used as controls.
All confocal imaging analyses were performed with a
BioRad MRC1024ES confocal laser scanning microscope. The
real time imaging on cells preloaded with DCFDA was car-
ried out with a 40X water immersion lens using the 488 nm
excitation laser line and simultaneous dual display mode (522
nm emission and phase-contrast) of the BioRad LaserSharp
imaging program. Each image series was collected under the
same system settings, such as the black level and the magnifi-
cation, using 10% laser intensity and 0.5 s/frame (512x512)
scan speed. Five random images were collected as determined
under phase-contrast/transmitting channel for focus and
confluence of cells within the frame (usually covering >90%
areas of 512x512 image frame that yields about 90-100 cell
per frame) at each of the given time points. Average fluores-
cence intensities were determined from each of the images
using the BioRad LaserSharp program. Data from five ran-
dom images within a given time point were pooled and aver-
aged again to obtain the mean fluorescence intensities.
Treatment of cells by inhibitors:  Cells were gradually
deprived of serum as described above and then treated with
various inhibitors before subjecting to PDGF stimulation. For
the treatment of PDGF receptor inhibitor 6,7-dimethoxy-3-
phenylquinoxaline (AG1296), EGF receptor inhibitor 4-[(3-
Bromophenyl)amino]-6,7-dimethoxyquinazoline (AG1517), G
protein coupled receptor (GPCR) inhibitor pertussis toxin
(Ptx), Src family kinases inhibitor, 4-amino-5-(4-
methylphenyl)-7-(t-butyl) pyrazolo [3,4-d] pyrimidine (PP1),
or phosphatidylinositol 3 kinase (PI3K) inhibitor, 2-(4-
morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002),
serum-starved cells were loaded with AG1296 (20 µM, 30
min or 2.5 h), AG1517 (1 µM, 2.5 h), Ptx (250 or 500 ng/ml,
1 or 2.5 h), PP1 (10 µM or 20 µM, 30 min), or LY294002 (15
µM, 30 µM, 40 µM, 30 min), respectively either individually
or in combination prior to PDGF addition.
We chose these inhibitors as it has been shown previously
in other cell types, the beta receptor of PDGF, the Src-family
kinases, PI3K and GPCR are all initial downstream targets
for PDGF-binding at the receptor [45,53-58]. AG1296 is a
potent and specific inhibitor for PDGF receptor tyrosine ki-
nase [59]. This quinoxalin-type tyrphostin acts as an ATP-com-
petitive inhibitor of the receptor kinase, but does not interfere
with ligand binding or receptor dimerization. However, it does
affect the autophosphorylation of PDGF receptor [60]. AG1517
is a specific inhibitor for EGF receptor that acts by competing
for ATP binding sites with EGF. AG1517 can rapidly suppress
autophosphorylation of EGF receptor and therefore selectively
impedes EGF-mediated cellular processes. PP1 is a potent Src-
family-selective tyrosine kinase inhibitor [61], whose inhibi-
tory activity appeares to act through ATP-competitive bind-
ing by interacting with the active site of Src tyrosine kinases
[62]. LY294002 is a flavonoid quercetin based compound,
which can completely abolish PI3K activity by targeting the
ATP-binding site of the catalytic unit p110 only [63,64], and
has no inhibitory effect on other ATP-requiring tyrosine ki-
nases [64]. We also chose to inhibit GPCR as recent reports
have indicated that GPCR plays a major role in growth factor
signaling [45,57,65-67]. Ptx, which is a secretory product of
Bordetella pertussis, prevents guanyl nucleotide-induced dis-
sociation of Giα from Giβγ subunits, a process that is crucial
for the function of GPCR [68].
Cell proliferation detected by 5-bromodeoxyuridine
(BrdU) incorporation assay:  5-Bromodeoxyuridine (BrdU),
a chemical analog of thymidine, was used in BrdU incorpora-
tion assay for cell proliferation. The method of using mono-
clonal antibodies directed against BrdU is often used to mea-
sure DNA synthesis, in which the amount of BrdU incorpo-
rated into cultured cells can be quantified chemiluminescently
in a luminometer.
BrdU incorporation assay was performed according to the
manufacturer instruction. Briefly, cells were seeded onto black
96-well plates overnight and medium was replaced with 2%
FBS-containing MEM for another overnight. BrdU labeling
solution (final concentration of 10 µM) and PDGF (1 ng/ml)
were added onto serum-starved cells and incubated for 1 h.
After labeling, cells were fixed and incubated with anti-BrdU-
POD. Excess antibody was removed by washing the cells with
1X PBS, and the chemiluminescence was determined by
luminometer equipped with automatic substrate injectors
(FLUOstar OPTIMA manufactured by BMG Labtech). The
specific chemiluminescence was expressed as RLU/second.
Western blot analysis:  The serum-deprived cells (wild-
type or transfected) preloaded with or without various inhibi-
tors, as described above, were treated with PDGF at various
time periods. Western blot analysis was performed as described
in Chen et al. [48].
Protein determination and statistical analysis:  Protein
concentration was determined by BCA microanalysis [69].
Statistical analysis was done using Student’s t-test. An associ-
ated probability (p) value of <0.05 was considered signifi-
cant.
RESULTS
Effect of inhibition on PDGF receptors, Src-family kinases,
PI3K, and GPCR on PDGF-stimulated ROS generation in
human lens epithelial (HLE) B3 cells:  To examine the effect
of PDGF binding on its downstream targets with and without
the presence of specific inhibitor to either PDGFR, Src-fam-
ily kinases, PI3K or GPCR, we monitored the change in PDGF-
stimulated ROS generation by capturing the fluorescence
emitted from the live cells using confocal microscopy. DCF
fluorescence intensity from the unstimulated cells was stan-
dardized to 100% and used as control. All other cells stimu-
lated by PDGF with and without inhibitor were compared for
fluorescent intensity relative to control cells. As shown in Fig-
ure 1, PDGF stimulation nearly doubled the fluorescent inten-
sity over the control. However, inhibition of PDGFR
(AG1296), Src-family kinases (PP1), or PI3K (LY294002)
completely abolished (AG1296, 30 min), substantially attenu-
ated (PP1 and LY294002, both 30 min), or partially attenu-
ated (pertussis toxin, 1 h) fluorescence production.
Effect of inhibition on PDGF, EGF and G protein coupled
receptors on PDGF-stimulated signaling components in hu-
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376man lens epithelial (HLE) B3 cells:  Western blot analyses
were performed on lysates of cells treated with various con-
centrations of inhibitors to the PDGFR (AG1296), EGFR
(AG1517) and GPCR (Ptx), either individually or in combi-
nation, in the presence of PDGF (1 ng/ml) for different peri-
ods of time (0, 10, 20, and 30 min). To ensure the concentra-
tions of inhibitors and the incubation time used during the
treatment were not harmful to the cells, LDH cytotoxicity as-
say was carried out in these cells and found no cell damage
under the experimental conditions (data not shown).
Effect of AG1296 (PDGFR inhibitor):  We have demon-
strated in the past that PDGF stimulation in HLE B3 cells
activated ERK1/2 and JNK specifically [48]. The effect of
these inhibitors on ERK1/2 and JNK were examined along
with Akt, which is the downstream target for PI3K activation,
and an important signaling component in cell survival in the
lens [70]. As shown in Figure 2A, ERK1/2, JNK and Akt in
the PDGF-stimulated control cells were all transiently acti-
vated, which began at 10 min and lasted until 30 min after
PDGF stimulation. However, AG1296 (20 µM) severely sup-
pressed Akt activation, substantially diminished the activa-
tions of ERK1/2 and JNK but did not affect P-p38 in cells
stimulated with PDGF, indicating that AG1296 was specifi-
cally targeting ERK1/2 and JNK, but not the stress-associated
p38. The constant level of G3PD in the immunoblot confirmed
that equal amounts of proteins were loaded onto the gel.
Effect of AG1517 (EGFR inhibitor):  An EGFR inhibitor
was used to investigate if PDGF-stimulated cells may use the
transactivation mechanism via EGF receptor. As shown in
Figure 2B, inhibiting the cells with AG1517 (1 µM, 2.5 h)
mildly diminishes PDGF-stimulated ERK1/2, JNK and Akt
but has no effect on p38. These results suggest that HLE B3
cells have a transactivation system between PDGFR and
EGFR, or that HLE B3 cells can partially rely upon the EGF
receptor for PDGF signaling.
Effect of pertussis toxin:  Figure 2C depicts the western
blot analysis of cells treated with pertussis toxin (500 ng/ml,
2.5 h), in which both ERK1/2 and JNK showed notably lower
activation levels while Akt activation was extensively de-
creased. Again these inhibitions were very specifically targeted
to the signal pathways of cell proliferation and cell survival,
as there was no change on the level of phosphorylated p38.
Therefore, the data suggest that crosstalk between the recep-
tors of G-coupled protein and PDGF may exist, or the HLE
B3 cells use GPCR in part for PDGF signaling.
Effect of inhibition on multiple receptors:  When the cells
were inhibited simultaneously by PDGFR and EGFR inhibi-
tors (AG1296 and AG1517), the downstream signals were ei-
ther completely shutoff (Akt) or severely inhibited (ERK1/2
and JNK). Cells treated simultaneously with inhibitors to all
three receptors (PDGF, EGF and GPC receptors) could no
longer being stimulated by PDGF as the combined inhibition
diminished the signals in ERK and JNK pathways to the basal
levels and completely abolished Akt activation. These results
are summarized in Figure 2D. Coinhibition of PDGFR and
GPCR with 20 µM of AG 1296 and 250 ng/ml of Ptx in cells
stimulated with PDGF also led to diminished activation in
ERK1/2 and JNK, and severely suppressed P-Akt (Figure 2E).
Inhibition effect of Src-family kinases and PI3K on the
PDGF-stimulated signaling components in human lens epi-
thelial (HLE) B3 cell:  The target proteins immediately down-
stream of PDGF receptor activation were examined for their
respective role in cell signaling. Src-family kinases were stud-
ied using a specific inhibitor, PP1, while PI3K was studied by
using LY294002.
Effect of Src inhibition by PP1:  Figure 3A depicts the
western blotting of cells treated with PP1 (10 µM or 20 µM,
30 min), which clearly shows a near-complete suppression of
ERK1/2, JNK and Akt activation in cells exposed to PP1 at
both low and high concentrations. Similar to AG1296 above,
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Figure 1. Confocal images of intracellular ROS generation upon plate-
let-derived growth factor (PDGF) stimulation in live HLE B3 cells.
Live HLE B3 cells were preloaded with DCFDA (50 µM) to capture
the ROS generated upon PDGF (1 ng/ml) stimulation. Confocal cell
images represent a random field after PDGF exposure. For further
details see Methods. A: Panels from left to right in following condi-
tions: control cells (no PDGF); control cells (with PDGF); PDGF-
stimulated cells pretreated with PDGF receptor inhibitor, AG1296
(20 µM, 30 min); PDGF-stimulated cells pretreated with Src inhibi-
tor, PP1 (10 µM, 30 min); PDGF-stimulated cells pretreated with
PI3K inhibitor, LY294002 (15 µM, 30 min); and PDGF-stimulated cells pretreated with inhibitor to G-protein coupled receptor, pertussis
toxin or Ptx (500 ng/ml, 1 h). B: Bar graph corresponding to the confocal images in A. The DCF fluorescent intensity was quantified using
Confocal Assistant 4.02, and expressed as percent increase normalized to control (100%). The data are expressed as mean±SD with n=3. Each
p value was obtained by using inhibitor against control (with PDGF). The asterisk indicates a p<8x10-5.
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Figure 2. Effect of receptor inhibition on PDGF-
activated MAP kinases in HLE B3 cells.  Serum-
deprived cells with and without inhibitor preloading
were stimulated with PDGF (1 ng/ml) for 0, 10,
20, and 30 min, harvested and then lysed in lysis
buffer. Cell lysates were applied on 10% SDS-
PAGE, transblotted and probed with specific anti-
bodies to P-ERK1/2, P-JNK, P-Akt, P-p38, and
G3PD, respectively. A: Cells were stimulated with
PDGF with and without preloading (2.5 h) of PDGF
receptor inhibitor, AG1296 (20 µM). B: Cells were
stimulated with PDGF with and without preloading
(2.5 h) with EGF receptor inhibitor, AG1517 (1
µM). C: Cells were stimulated with PDGF with and
without preloading (2.5 h) with pertussis toxin (Ptx,
500 ng/ml). D: Cells were stimulated with and with-
out preloading (2.5 h) with AG1296 (20 µM) +
AG1517 (1 µM), or AG1296 (20 µM) + AG1517
(1 µM) + Ptx (500 ng/ml). E: Cells were stimu-
lated with and without preloading (overnight) with
AG1296 (20 µM) + Ptx (250 ng/ml). Cells without
treatment of inhibitors but with stimulation of
PDGF (1 ng/ml) were used as the controls. The bar
graph with averaged pixel values of the band in-
tensities for each western blot is shown. Data pre-
sented are a typical representation of triplicate ex-
periments. This figure continues on the next page.
378PP1 inhibition is specific for ERK1/2 and JNK signaling com-
ponents but not p38, which remained unchanged during PP1
inhibition.
Effect of PI3K inhibition by LY294002:  Figure 3B repre-
sents the western blotting for the lysates from cells treated
with LY294002 (15 µM, or 40 µM, 30 min). As expected, Akt
showed no activation signal in the presence of PI3K inhibitor,
which appeared to be very specific to Akt and had little effect
on other signaling pathways, including ERK1/2, JNK and p38.
Effect of inhibition of PDGF receptors, Src-family kinases,
PI3K and GPCR on cell proliferation in human lens epithe-
lial (HLE) B3 cells:  In our previous report [48], we have il-
lustrated the importance of ROS generation towards cell pro-
liferation. In this study, the inhibitory effect of PDGFR, Src-
family kinase, PI3K and GPCR on cell growth was evaluated
using BrdU incorporation assay. Figure 4 represents the quan-
tity of incorporated BrdU in the cells treated with AG1296
(20 µM, 30 min), PP1 (10 µM, 30 min), LY294002 (30 µM,
30 min) or pertussis toxin (500 ng/ml, overnight) with or with-
out PDGF (1 ng/ml) stimulation. It shows that PDGF-stimu-
lated cell proliferation was nearly 30% higher than that of the
unstimulated cells (control). Inhibiting PDGFR (AG1296),
Src-family kinases (PP1), or GPCR (pertussis toxin) eradi-
cated new DNA synthesis. However, inhibiting PI3K showed
suppressed cell growth so much so that it was below the con-
trol. All these indicate that PDGFR and its receptor phospho-
rylated sites in binding with PI3K, Src-family kinases are es-
sential for PDGF mitogenic action, and GPCR also plays an
important role.
In another BrdU experiment, cell growth was monitored
using individual specific inhibitors to PDGFR (AG1296, 20
µM for 2.5 h), EGFR (AG 1517, 1 µM for 2.5 h) or GPCR
(Ptx, 500 ng/ml for 2.5 h), or in combined inhibitions of
PDGFR + EGFR, or PDGFR + EGFR + GPCR. In compari-
son to the untreated control cells, each inhibitory condition
showed a near total suppression of PDGF-stimulated cell
growth (data not shown), consistent with the results on the
attenuated MAPK signaling when the inhibitors were used
under the same experimental conditions.
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Figure 2. Continued from previous page.
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Figure 3. Effect of Src and PI3K inhibition on
PDGF-stimulated MAP Kinases in HLEB3
cells.  Serum-deprived cells with and without
inhibitor preloading were stimulated with
PDGF (1 ng/ml) for 0, 10, 20, and 30 min,
harvested and then lysed in lysis buffer. Cell
lysates were applied on 10% SDS-PAGE,
transblotted and probed with specific antibod-
ies to P-ERK1/2, P-JNK, P-Akt, P-p38, and
G3PD, respectively. A: Cells were stimulated
with PDGF with and without preloading (30
min) of Src inhibitor, PP1, at 10 µM or 20 µM.
B: Cells were stimulated with PDGF with or
without preloading (30 min) of PI3K inhibi-
tor, LY294002 at 15 µM or 40 µM. Cells with-
out treatment of inhibitor but with stimulation
of PDGF (1 ng/ml) were used as the control.
The bar graph with averaged pixel values of
the band intensities for each western blot is
shown. Data presented are a typical represen-
tation of 2-3 separate experiments.
Figure 4. Determination of PDGF-stimulated
cell proliferation in the presence or absence
of inhibitors by BrdU incorporation assay.
DNA synthesis induced by PDGF (1 ng/ml,
60 min) in cells with and without pretreatment
of PDGF receptor inhibitor, AG1296 (20 µM,
overnight), Src inhibitor, PP1 (10 µM, 30 min),
PI3K inhibitor, LY294002 (30 µM, 30 min)
or GPCR inhibitor, pertussis toxin (500 ng/
ml, overnight) was measured by BrdU incor-
poration. Control cells (no inhibitor), were
included for comparison. The data are ex-
pressed as relative luminescence unit (RLU)/
sec, with mean±SD (n=12). The results are
from 3 separate experiments. Each p value was
obtained by using inhibitor (with PDGF)
against control (with PDGF). The asterisk in-
dicates a p<0.001 and the double asterisk de-
notes a p<0.026.
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Figure 5. Western blot analysis of PDGF-activated MAP
kinases in Ras or Rac transfected human lens epithelial
B3 cells.  Serum-deprived transiently transfected cells
with and without inhibitor pretreatment were stimulated
with PDGF (1 ng/ml) for 0, 10, 20, and 30 min, har-
vested and then lysed in lysis buffer. The vector-trans-
fected cells were used as control. Cell lysates were ap-
plied on 10% SDS-PAGE, transblotted and probed with
specific antibodies to HA, P-ERK1/2, P-JNK, P-Akt,
P-p38, and G3PD. A: Wild type (WT) and transfected
cells (Rac N17, Rac V12, Ras N17) were probed with
anti-HA antibody. B: Vector- or Rac N17-transfected
cells stimulated with PDGF were probed for P-ERK1/
2, P-JNK, P-Akt, P-p38, and G3PD. C: Vector- or Rac
V12-transfected cells stimulated with PDGF were
probed for P-ERK1/2, P-JNK, P-Akt, P-p38 and G3PD.
D: Vector- or Ras N17-transfected cells stimulated with
PDGF were probed for P-ERK1/2, P-JNK, P-Akt, P-
p38 and G3PD. The bar graph with averaged pixel val-
ues of the band intensities for each western blot is shown.
Data presented are a typical representation of 2-3 sepa-
rate experiments.
381The role of small GTP-binding proteins Rac and Ras in
PDGF-stimulated ROS generation in human lens epithelial
(HLE) B3 cells:  To examine the importance of Rac or Ras in
PDGF-stimulated signaling, we used cells transfected with
dominant negative Ras (Ras N17), dominant negative Rac (Rac
N17) or constitutive active Rac (Rac V12) for evaluation.
Western blot analysis was performed on HA-tag to ensure that
HA-tagged cDNA was successfully transfected into HLE B3
cells. As shown in Figure 5A, all three transfectants (Rac N17,
Rac V12, and Ras N17) contain HA-tag but no tag was found
in the empty vector-transfected wild type (WT). The confocal
images of vector, Rac N17, Rac V12 or Ras N17 transfected
cells stimulated with PDGF (1 ng/ml) as compared with the
un-stimulated control are shown in Figure 6A. The DCF fluo-
rescence was clearly visible in vector-transfected cells stimu-
lated with PDGF. In contrast, cells without PDGF stimulation
at the same period of time (10 min) barely showed visible
fluorescence. Upon PDGF stimulation, both the Rac N17- and
Ras N17-transfected cells had only basal levels of fluores-
cence, while Rac V12-transfected cells were insensitive to
PDGF, and had a consistently high level of fluorescence even
in the absence of PDGF (Data not shown). The relative DCF
intensity of each condition is summarized in Figure 6B.
Small GTP-binding proteins Rac and Ras are important
for MAPK activation stimulated by PDGF in human lens epi-
thelial (HLE) B3 cells:  Cell lysates from each transfectant,
including Rac N17, Rac V12, Ras N17 and the control (vector
only), were analyzed for the activations of ERK1/2, JNK, Akt,
and p38. G3PD was also analyzed to ensure equal amounts of
protein were applied. As shown in Figure 5B, Rac N17 trans-
fected cells have shorter duration and weaker activations in
ERK1/2, JNK, but no visible change in p38 when compared
with the vector control. Rac N17 effect on Akt is minimal.
Rac V12 transfected cells, on the other hand, showed prolonged
activations and intensified signals for both ERK1/2 and JNK
but had no effect on Akt or p38 (Figure 5C). Ras N17
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Figure 6. Confocal images of intracellular ROS generation upon
PDGF stimulation in live Ras or Rac transfected cells.  Serum starved
transiently transfected cells were preloaded with DCFDA (50 µM)
to capture the ROS generated upon PDGF (1 ng/ml) stimulation.
Confocal cell images represent a random field after PDGF exposure.
For details see Methods. A: Panels from left to right are: Negative
control cells (vector transfected, no PDGF); positive control cells
(vector transfected, with PDGF), dominant negative Rac transfected
cells (Rac N17, with PDGF), constitutively active Rac tansfected
cells (Rac V12, with PDGF), and dominant negative Ras transfected
cells (Ras N17, with PDGF). B: Bar graph corresponding to the con-
Figure 7. Determination of PDGF-stimulated cell proliferation in Ras
or Rac transfected cells by BrdU incorporation assay.  DNA synthe-
sis was measured with or without addition of PDGF (1 ng/ml, 60
min) in transient tranfectants: vector (control), Rac N17, Ras N17,
and Rac V12. The data are expressed as relative luminescence unit
(RLU)/sec with mean±SD (n=12). The results are from 3 separate
experiments. Each p value was obtained by using mutant transfectant
(with PDGF) against vector transfectant (with PDGF). The asterisk
indicates a p<1x10-7.
focal images in A. The DCF fluorescent intensity was quantified using Confocal Assistant 4.02, and expressed as precent increase normalized
to control (100%). The data are expressed as mean±SD with n=3. Each p value was obtained by using mutant transfectant against vector
trasnfectant (with PDGF). The asterisk indicates a p<2x10-5 and the double asterisk denotes a p<0.03.
382transfectant showed similar effect on these signaling compo-
nents as Rac N17, except that the non-functional Ras appeared
to reduce activated Akt more effectively (Figure 5D). These
results suggest that both Rac and Ras are essential regulators
for PDGF signaling.
The role of small GTP-binding proteins Rac and Ras on
cell proliferation stimulated by PDGF in human lens epithe-
lial (HLE) B3 cells:  The effect of Rac and Ras on cell prolif-
eration was demonstrated using BrdU incorporation assay. As
shown in Figure 7, the control cells (vector only) increased
DNA synthesis 30% after PDGF stimulation. Cells with domi-
nant negative Rac (Rac N17) or Ras (Ras N17) had only 50%
of the proliferation rate when compared with the control, and
these transfectant cells are insensitive to PDGF stimulation.
In contrast, the constitutively active Rac cells (Rac V12) ex-
hibit higher growth rate than the control cells, with and with-
out PDGF stimulation. Cell proliferation was also examined
in these dominant negative and constitutively active cells us-
ing 3H-thymidine incorporation assay. The results showed sup-
pression of DNA synthesis in Rac N17 or Ras N17 transfected
cells with or without stimulation of PDGF, while no suppres-
sion was seen in Rac V12 transfected cells (data not shown).
These findings suggest that both functional Rac and Ras are
essential proteins for PDGF-stimulated cell proliferation.
DISCUSSION
 PDGF ββ binding to the receptor in many cell types is known
to induce several signaling pathways that lead to various cel-
lular functions. It become clear in recent years, that PDGF
mitogenic action is mediated by ROS generated during the
process for the downstream signaling transduction cascades
[35]. In our previous report [48], we demonstrated that the
production of ROS in lens epithelial cells was triggered by
PDGF, and linked with the subsequent transient ERK1/2 and
JNK activations as well as cell growth. The current report not
only confirmed our previous study but also further identified
that PDGFR and its associated early binding proteins, includ-
ing Src-family kinases, PI3K, and the small GTP-binding pro-
teins of Rac and Ras, are essential elements for PDGF signal-
ing induced cell proliferation. Our data suggest that the PDGF
mitogenic action in human lens epithelial cells is regulated by
the collective effort of these membrane-associated target pro-
teins, similar to other cell types [55,71-75].
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Figure 8. The proposed mechanism of PDGF signaling in the lens epithelial cells.  The solid line indicates the known or published pathway and
the dashed line represents proposed new pathway. In the figure, EGF denotes Epidermal growth factor, GPCR indicates G protein coupled
receptor, PI3K indicates phosphatidyl inositol-3-kinase, cPLA2 denotes cytosolic phospholipase 2, PL indicates Phospholipid, AA denotes
Arachidonic acid, PKC indicates protein kinase C, and ROS denotes Reactive oxygen species.
383It is interesting that the inhibitor specific to PDGFR could
eliminate PDGF-stimulated ROS generation, but could not
inhibit ERK1/2 or JNK activation completely (Figure 2A).
This phenomenon suggests that the cell may deliver the PDGF
signal via other receptors [76]. It was shown in rat aortic vas-
cular smooth muscle cells that PDGF ββ could transactivate
EGF receptor to form a heterodimer between PDGFR and
EGFR, which contributed to ERK1/2 activation. These au-
thors also showed that antioxidants or Src inhibitor, but not
PDGFR kinase specific inhibitor (AG 1295), could disrupt
this receptor heterodimer, indicating that PDGFR kinase was
not involved in the heterodimer activity. Furthermore, PDGF
could also transactivate FGFR-1 and released bFGF in smooth
muscle cells to enhance cell proliferation [77]. It is likely that
a similar transactivation may occur in HLE cells, and the re-
sidual P-ERK1/2 signal during PDGFR inhibition observed
in this study may be attributed to PDGF transactivated EGF
or FGF signaling. However, HLE B3 cell is known to lack
bFGF receptors and has a lower number of EGF receptors
than PDGF receptors [78]. Thus, we speculate that the residual
MAPK signaling could only be contributed from EGFR acti-
vation. Our current data did show that inhibition of EGFR
negatively influenced the PDGF-stimulated ERK1/2, JNK and
Akt signaling (Figure 2B) while inhibiting both receptors ter-
minated Akt signal and rendered severely suppressed signals
of ERK1/2 and JNK (Figure 2D). These data indicate that
transactivation between PDGF and EGF receptors is likely
functional in the lens epithelial cells.
It is intriguing that inhibition of GPCR by pertussis toxin,
a Giα protein inhibitor, could partially suppress PDGF-induced
ROS production, and the downstream ERK1/2, JNK, and Akt
activations (Figure 1 and Figure 2C), albeit the inhibition was
less effective as that of other inhibitors used in this study. This
crosstalk between GPCR and PDGFββ-activated PDGFR is a
novel finding in the lens epithelial cells. Recent studies have
demonstrated a co-mitogenicity in a number of growth fac-
tors (for examples, EGF, IGF-1, and PDGF) to stimulate
MAPK cascades via GPCR-mediated pathways in numerous
cell types [58,79-83]. This new signaling system, called inte-
grative signaling, is distinct from the transactivation of growth
factors mentioned above, as it works via intimate binding of
the components in two receptors between the receptor of pro-
tein tyrosine kinase (PTKR) and GPCR. Activation of this
PTKR-GPCR complex is mediated by cytosolic Src and other
adaptor proteins, to initiate MAPK signaling [79,84,85]. Dis-
rupting GPCR would therefore destroy this complex and at-
tenuate MAPK activation [45]. Indeed, we have observed a
diminished MAPK signaling by co-inhibition of PDGFR and
GPCR (Figure 2E), more so by co-inhibition of PDGFR,
EGFR, and GPCR (Figure 2D), and a complete shutdown of
MAPK signaling by inhibiting Src-family kinases (Figure 3A).
All are indicative of the presence of this receptor-complex. If
GPCR were associated with PDGFR binding through Src in
our system, it would be reasonable to expect that inhibition of
GPCR would affect the docking efficiency of Src and the down-
stream target proteins, including PI3K and MAPK pathways
of ERK1/2 and JNK, as we have observed in this study.
Of all the inhibitors used, the PP1 specific inhibitor for
Src-family kinases was the most effective as it could shut-
down all three signaling pathways of ERK1/2, JNK, and Akt
(Figure 3A). The inhibition was specific as p38 pathway was
not affected. Src-family kinases are involved in many down-
stream signaling pathways [60] and they are also involved in
the above-mentioned transactivation of heterodimer of PDGFR
and EGFR [76]. Therefore, the strong inhibitory effect of Src-
family kinases by PP1 in suppressing ROS production, MAPK
activations and cell proliferation observed in our study is to
be expected.
The importance of PI3K in PDGF mitogenic action has
been established in various cell types. Bae et al. [15] has dem-
onstrated that PDGF-induced ROS production requires PI3K
activation, indicating that ROS generation is downstream from
PI3K. It is known that PI3K activates Rac, which is an essen-
tial active component during NADPH oxidase activation [16].
Thus, both PI3K and Rac are necessary for ROS production.
In our current study, the specific inhibitor to PI3K (LY294002)
effectively eliminated the fluorescent production from intrac-
ellular ROS in HLE cells during PDGF stimulation (Figure
1). Inhibiting PI3K also eliminated Akt activation as expected,
but it had no effect on ERK1/2 and only weakly attenuated P-
JNK (Figure 3B). It is known that activation of JNK is down-
stream from Rac [73], thus, it is reasonable to expect that some
inhibitory effect on JNK activation would occur. However,
inhibition of PI3K may have limited effect on P-ERK1/2 as
activation of ERK1/2 can be initiated from several sources
besides PI3K, including Ras, and to some degree from βγ
heterodimer-activated receptor tyrosine kinases during GPCR
activation [79,80].
Cells transfected with constitutively active Rac plasmid
(Rac V12), showed a similar increase in fluorescence as the
vector transfected cells (44-50%) during PDGF stimulation,
but the basal level of fluorescence was considerably higher in
the Rac V12 than that of vector transfected cells (data not
shown). In contrast, cells transfected with dominant negative
Rac (Rac N17) could not produce any ROS upon PDGF stimu-
lation (Figure 6). As expected, genetic manipulation of Rac
changed the up and down signals of P-JNK but had less effect
on ERK1/2 (Figure 5B). Dominant negative Ras also prevented
ROS generation and shortened the duration of activated MAPK
pathways, except p38, indicating that Ras occupies the initial
stage of the PDGF signaling system.
Taken together, our data indicate that ROS generation,
the downstream MAPK activation, and the cell proliferation
upon PDGF stimulation require the concerted effort of the up-
stream membrane-associated components of PDGF receptor
kinase, Src-family kinases, PI3K and the GTP-binding pro-
teins of Rac and Ras. We speculate that GPCR and EGFR
may also play a regulatory role in this process. These findings
provide an insight into the mechanistic regulatory system for
the complex PDGF signaling pathway in the lens epithelial
cells. Our previous report [51], which focused on the path-
ways downstream from the factors covered in this study, dem-
onstrated that PDGF-stimulated ERK1/2 activation induced
arachidonic acid release to facilitate ROS production from
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384NADPH oxidase. We have thus proposed that the mechanism
of PDGF stimulation may use a positive feedback loop of
PDGFR-ERK1/2-arachidonic acid-ROS-ERK1/2-cell prolif-
eration. Together with our findings on the regulatory compo-
nents upstream from our previous work, we propose the fol-
lowing mechanism of PDGF signaling in the lens epithelial
cells as depicted in Figure 8.
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